SPRINGWORKS THERAPEUTICS, INC. (SWTX): Price and Financial Metrics
SWTX Price/Volume Stats
| Current price | $51.14 | 52-week high | $62.00 |
| Prev. close | $49.77 | 52-week low | $28.21 |
| Day low | $48.94 | Volume | 1,699,600 |
| Day high | $51.51 | Avg. volume | 2,663,253 |
| 50-day MA | $45.33 | Dividend yield | N/A |
| 200-day MA | $38.74 | Market Cap | 3.83B |
SWTX Stock Price Chart Interactive Chart >
SPRINGWORKS THERAPEUTICS, INC. (SWTX) Company Bio
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
SWTX Price Returns
| 1-mo | -12.72% |
| 3-mo | 33.52% |
| 6-mo | 43.81% |
| 1-year | 1.71% |
| 3-year | -15.46% |
| 5-year | 150.20% |
| YTD | 41.54% |
| 2024 | -1.01% |
| 2023 | 40.33% |
| 2022 | -58.03% |
| 2021 | -14.53% |
| 2020 | 88.41% |
Loading social stream, please wait...